Herpes simplex virus type 2 and cancer: A medical geography approach
✍ Scribed by Frédéric Thomas; Eric Elguero; Jacques Brodeur; Jerome Le Goff; Dorothée Missé
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 185 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1567-1348
No coin nor oath required. For personal study only.
✦ Synopsis
Herpes simplex virus type-2 (HSV-2) has been identified as a possible aetiological agent of cancer in humans, especially prostate cancer, but results remain controversial. Here, we have addressed this question using a medical geography approach based on the national incidence of various cancers and seroprevalence of HSV-2 in 64 countries worldwide. We corrected reports of cancer incidence for national gross domestic product (GDP) because living in a wealthy nation likely increases the probability of having a cancer detected. Data were also corrected for latitude and diet. Our analysis not only confirms that prostate cancer and HSV-2 seroprevalence are positively associated, but it also reveals the existence of a positive relationship between HSV-2 and melanoma incidence in both men and women. These results, though correlational, suggest that HSV-2 should continue to be investigated as a possible oncogenic pathogen of humans.
📜 SIMILAR VOLUMES
## Abstract A small‐plaque mutant (No. 69) of herpes simplex virus type 2 (HSV‐2) strain 333 has been previously isolated and characterized in this laboratory. This mutant was shown to produce a high ratio of noninfectious to infectious particles when grown at the nonpermissive temperature in hamst
## Abstract The association between sexual activity and human herpes virus‐8 (HHV‐8) infection has been established, but the mode of acquisition is still unclear. Blood samples from 238 individuals from Northern Cameroon were tested to evaluate the incidence of herpes simplex virus‐2 (HSV‐2), human